Navigation Links
Tennis star's hospitalization for altitude sickness

New Rochelle, NY, December 16, 2010 Former tennis champion Martina Navratilova was hospitalized for pulmonary edemafluid build-up in the lungswhile climbing Mount Kilimanjaro, drawing attention to the high risk of acute mountain sickness (AMS) and high altitude pulmonary edema among climbers of high peaks. A timely study in a recent issue of High Altitude Medicine & Biology, a peer-reviewed journal published by Mary Ann Liebert, Inc. (, warned of the risks and serious medical outcomes associated with climbing Kilimanjaro and demonstrated that prior acclimatization to increased altitude can help protect against the development of AMS. The paper is available free online at

Altitude-related medical problems during the ascent of Mount Kilimanjaro are relatively common. Pulmonary edema is a more serious disorder than some more common forms of acute mountain sickness.

The study published in High Altitude Medicine & Biology, entitled "Incidence and predictors of acute mountain sickness among trekkers on Mount Kilimanjaro," evaluated the incidence of AMS among trekkers of this popular climbing destination. Steward Jackson, J. Kenneth Baillie, and colleagues from University of Edinburgh (Scotland) and Muhimbili University College of Health Science (Tanzania), compared the protective effect of a single rest day during the climb, use of prophylactic acetazolamide (a drug with diuretic properties that inhibits fluid retention), or acclimatization to increased altitude prior to the climb on the risk of AMS.

Ms. Navratilova was a powerful, fit, and dominant player throughout her professional career, and this incidence of altitude sickness in an athlete of her stature shows that "good fitness at sea level does not ensure protection from high altitude illnesses," says John B. West, MD, PhD, Editor-in-Chief of High Altitude Medicine & Biology and Professor of Medicine at University of California, San Diego School of Medicine.


Contact: Vicki Cohn
Mary Ann Liebert, Inc./Genetic Engineering News

Related biology news :

1. Gold nanostars outshine the competition
2. Australian filmmakers are stars of science film awards
3. Study: Sea stars bulk up to beat the heat
4. Luteolin stars in study of healthful plant compounds
5. Reducing risk of hospitalization in the elderly
6. Pollution linked to hospitalizations for pneumonia in older adults
7. Personalized diets for elderly after hospitalization decreases mortality rates
8. UCSD researchers make first direct observations of biological particles in high-altitude ice clouds
9. Babies born to native high-altitude mothers have decreased risk of low birth weight
10. Winter Olympics: Altitude affects skill sports, not just endurance events
11. High-altitude research advances low-altitude medicine
Post Your Comments:
Related Image:
Tennis star's hospitalization for altitude sickness
(Date:6/16/2016)... FRANCISCO , June 16, 2016 ... size is expected to reach USD 1.83 ... by Grand View Research, Inc. Technological proliferation and ... banking applications are expected to drive the market ... ) , The development of advanced ...
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:5/24/2016)... care by providing unparalleled technology to leaders of the medical imaging industry.  As such, ... to the range of products distributed by Ampronix. Photo - ... ... ... With ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... June 27, 2016   Ginkgo Bioworks , a ... engineering, was today awarded as one of the ... the world,s most innovative companies. Ginkgo Bioworks is ... the real world in the nutrition, health and ... directly with customers including Fortune 500 companies to ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Researchers at ... most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the ... read it now. , Diagnostic biomarkers are signposts in the blood, lung fluid ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
Breaking Biology Technology: